Thomas W. Elward has been the CEO of Dyne Therapeutics, Inc. since 2011. He has a strong background in the energy industry, having previously served as President and COO of CMS Enterprises, where he gained extensive management experience. Elward also...
Thomas W. Elward has been the CEO of Dyne Therapeutics, Inc. since 2011. He has a strong background in the energy industry, having previously served as President and COO of CMS Enterprises, where he gained extensive management experience. Elward also has technical expertise with a master's degree in nuclear engineering. He has played a significant role in various power-related projects and has received awards for excellence in safety and environmental stewardship. Interestingly, he takes a hands-on approach to leadership and is actively involved in major decisions, including the CEO search for Dyne. In 2023, his compensation totalled approximately $756,786, but what stands out is his historical compensation peaked at over $8.3 million in 2016. Elward's stock holdings have seen significant fluctuations, showing he has a vested interest in Dyne's performance, which aligns with his leadership style. Despite ups and downs in the stock value throughout his career, Elward continues to focus on scaling the company, which is essential for its growth and survival in a competitive market.